2024 annual financial data
Eloxx Pharmaceuticals 2024 Operating cash flow growth
Direct answer
Operating cash flow growth was 67.12%.
Operating income was -2,468,000 USD and net income was -3,143,000 USD.
Operating cash flow was -4,715,000 USD.
Get free Eloxx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,359,000 USD
- Operating income
- -2,468,000 USD
- Net income
- -3,143,000 USD
- Operating cash flow
- -4,715,000 USD